Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
Voprosy Onkologii
|
January 1, 1980
[Morphological criteria of lung cancer regression under the effect of magnetotherapy]
L S Ogorodnikova, N G Gaĭrabed'iants, O N Ratner, et al.
Oncogene
|
March 13, 2001
The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells
G A Mashour, N Ratner, G A Khan, et al.
Glia
|
September 1, 1995
Regulation of neurofibromin expression in rat sciatic nerve and cultured Schwann cells
L Wrabetz, M L Feltri, H Kim, et al.
Brain Research
|
January 8, 1999
Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor
T A Rizvi, S Akunuru, G de Courten-Myers, et al.
Grudnaia I Serdechno-Sosudistaia Khirurgiia
|
July 1, 1991
[Primary sarcomas of the lungs]
E M Nepomniashchaia, O N Ratner, E D Chirvina, et al.
Development (Cambridge, England)
|
November 1, 1995
Neurofibromin-deficient fibroblasts fail to form perineurium in vitro
T Rosenbaum, Y L Boissy, K Kombrinck, et al.
Neurology
|
April 1, 1997
Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force
K N North, V Riccardi, C Samango-Sprouse, et al.
Oncogene
|
November 12, 1998
Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells
P D Pelton, L S Sherman, T A Rizvi, et al.
The Journal of Clinical Investigation
|
May 3, 2000
Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models
J E DeClue, S Heffelfinger, G Benvenuto, et al.
Cell
|
April 17, 1992
Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis
J E DeClue, A G Papageorge, J A Fletcher, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
Voprosy Onkologii
|
January 1, 1980
[Morphological criteria of lung cancer regression under the effect of magnetotherapy]
L S Ogorodnikova, N G Gaĭrabed'iants, O N Ratner, et al.
Oncogene
|
March 13, 2001
The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells
G A Mashour, N Ratner, G A Khan, et al.
Glia
|
September 1, 1995
Regulation of neurofibromin expression in rat sciatic nerve and cultured Schwann cells
L Wrabetz, M L Feltri, H Kim, et al.
Brain Research
|
January 8, 1999
Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor
T A Rizvi, S Akunuru, G de Courten-Myers, et al.
Grudnaia I Serdechno-Sosudistaia Khirurgiia
|
July 1, 1991
[Primary sarcomas of the lungs]
E M Nepomniashchaia, O N Ratner, E D Chirvina, et al.
Development (Cambridge, England)
|
November 1, 1995
Neurofibromin-deficient fibroblasts fail to form perineurium in vitro
T Rosenbaum, Y L Boissy, K Kombrinck, et al.
Neurology
|
April 1, 1997
Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force
K N North, V Riccardi, C Samango-Sprouse, et al.
Oncogene
|
November 12, 1998
Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells
P D Pelton, L S Sherman, T A Rizvi, et al.
The Journal of Clinical Investigation
|
May 3, 2000
Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models
J E DeClue, S Heffelfinger, G Benvenuto, et al.
Cell
|
April 17, 1992
Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis
J E DeClue, A G Papageorge, J A Fletcher, et al.
Page
of 10